Vorinostat Related Products

Vorinostat, also known as suberoylanilide hydroxamic acid (SAHA), is a histone deacetylase (HDAC) inhibitor used in the treatment of cutaneous T-cell lymphoma (CTCL), a type of cancer that affects the skin and is part of a broader group of non-Hodgkin's lymphoma.

Vsquare is a leading innovator in pharmaceutical reference standards. We supply high-quality Reference Standards of Vorinostat, pharmacopeial and non-pharmacopeial Vorinostat impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Vorinostat impurities reference standards are useful in pharmaceutical research. They are useful in product development, ANDA and DMF filing, quality control (QC), method validation, and stability studies. It is also useful in the identification of unknown impurities and the assessment of genotoxic potential.

Vorinostat-related products are thoroughly characterized. Vorinostat products are supplied with detailed COA & analytical data meeting regulatory compliance. We can also provide EP/USP traceable standards based on your requirements. The supplied products are re-tested at regular intervals.